MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 269 filers reported holding MYRIAD GENETICS INC in Q3 2013. The put-call ratio across all filers is 2.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $28,195,000 | -30.7% | 827,803 | -21.5% | 0.84% | -40.1% |
| Q3 2014 | $40,692,000 | -4.2% | 1,055,014 | -3.3% | 1.41% | -4.3% |
| Q2 2014 | $42,471,000 | -31.6% | 1,091,227 | -40.0% | 1.47% | -39.5% |
| Q1 2014 | $62,137,000 | +92.5% | 1,817,401 | +18.1% | 2.44% | +86.1% |
| Q4 2013 | $32,282,000 | +9802.5% | 1,538,685 | +10989.6% | 1.31% | +8633.3% |
| Q3 2013 | $326,000 | – | 13,875 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |